Bellevue Group’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-836,190
Closed -$6.56M 186
2022
Q2
$6.56M Hold
836,190
0.09% 108
2022
Q1
$9.27M Hold
836,190
0.11% 106
2021
Q4
$14.7M Hold
836,190
0.15% 106
2021
Q3
$16.9M Hold
836,190
0.17% 104
2021
Q2
$27.6M Buy
836,190
+13,055
+2% +$493K 0.27% 96
2021
Q1
$32.2M Buy
823,135
+185,582
+29% +$8.71M 0.34% 87
2020
Q4
$27.8M Buy
637,553
+168,989
+36% +$5.77M 0.32% 82
2020
Q3
$13.3M Buy
468,564
+21,757
+5% +$687K 0.18% 102
2020
Q2
$16.2M Buy
446,807
+196,807
+79% +$5.54M 0.23% 88
2020
Q1
$4.54M Buy
+250,000
New +$5.48M 0.09% 116

Other funds holding ONEM

Bellevue Group's ONEM Position: Q3 2022 in Review

Bellevue Group sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 836,190 shares — an estimated $6.56M sold.

Bellevue Group first reported a position in ONEM in Q1 2020 and held it in 10 quarters. The position peaked at $32.2M in Q1 2021. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.

  • Bellevue Group reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
  • Bellevue Group sold 836,190 1Life Healthcare shares in Q3 2022, an estimated $6.56M.
  • Bellevue Group first reported a position in 1Life Healthcare in Q1 2020 and held it in 10 quarters.
  • Bellevue Group's 1Life Healthcare position peaked at $32.2M in Q1 2021.
  • 222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.

Based on Bellevue Group's 13F filing for Q3 2022, filed 14 Nov 2022.